SEC FORM 4
$147,773.87
GeneDx Holdings Corp. (WGS)
Sale of 1,525 shares at $96.9009 per share.
Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →